The TSEN54 gene pontocerebellar hypoplasia type 4 genetic test is a specialized diagnostic tool designed to detect mutations in the TSEN54 gene, which are associated with pontocerebellar hypoplasia type 4 (PCH4). PCH4 is a rare genetic disorder characterized by the underdevelopment of the cerebellum and brainstem, leading to significant neurological impairments. This condition is inherited in an autosomal recessive manner, meaning that a child must inherit two copies of the mutated gene, one from each parent, to be affected.
The test, offered by DNA Labs UAE, is crucial for early diagnosis and management of the condition. It involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory to identify any mutations in the TSEN54 gene. Early diagnosis through genetic testing can help in the planning of treatment and management strategies, offering insights into the prognosis and potential interventions to improve the quality of life for affected individuals.
The cost of the TSEN54 gene pontocerebellar hypoplasia type 4 genetic test at DNA Labs UAE is 4400 AED. This investment in genetic testing is vital for families with a history of the condition or those who have had children with similar symptoms, as it provides a definitive diagnosis, guiding further medical and supportive care decisions.
The TSEN54 gene pontocerebellar hypoplasia type 5 genetic test is a specialized diagnostic tool used to detect mutations in the TSEN54 gene, which are linked to pontocerebellar hypoplasia type 5 (PCH5). PCH5 is a rare genetic disorder characterized by the underdevelopment of the cerebellum and pons, two crucial parts of the brain involved in controlling movement, balance, and complex motor tasks. This condition leads to significant neurological impairments, including developmental delays, motor dysfunction, and in some cases, epilepsy.
The test is available at DNA Labs UAE, a leading genetic testing facility known for its advanced diagnostic services. The cost of the test is set at 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify mutations in the TSEN54 gene. This test is crucial for families seeking a definitive diagnosis of pontocerebellar hypoplasia type 5, as it provides essential information for understanding the condition, planning treatment strategies, and assessing the risk of recurrence in future pregnancies.
The RARS2 Gene Pontocerebellar Hypoplasia Type 6 Genetic Test is a specialized diagnostic procedure designed to identify mutations in the RARS2 gene, which are linked to Pontocerebellar Hypoplasia Type 6 (PCH6). This condition is a rare genetic disorder characterized by the underdevelopment of the cerebellum and pons, two critical regions of the brain, leading to severe neurological impairments. Symptoms can include delayed development, motor skills difficulties, and in some cases, seizures.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test aims to provide conclusive genetic evidence for the diagnosis of PCH6. This is crucial for the management and treatment of the condition, allowing for tailored care plans and informed genetic counseling for affected families. The test involves collecting a DNA sample, typically through a blood draw, and then examining the RARS2 gene for specific mutations known to cause the disorder.
The cost of the RARS2 Gene Pontocerebellar Hypoplasia Type 6 Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis required to detect the genetic variations associated with the condition, offering families critical insights into their genetic health and the potential risks for future offspring.
The PARK7 gene, also known as DJ-1, plays a significant role in protecting cells from oxidative stress and is involved in the regulation of gene expression and mitochondrial function. Mutations in the PARK7 gene are linked to the development of Parkinson's disease, a progressive neurological disorder characterized by tremors, stiffness, and difficulties with balance and coordination.
The PARK7 Parkinson Genetic Test is a specialized diagnostic tool designed to detect mutations in the PARK7 gene. This test is crucial for individuals with a family history of Parkinson's disease or those showing early symptoms of the condition, as it can provide valuable insights into their risk of developing the disease. Early detection through genetic testing can lead to a more tailored approach to treatment and management, potentially improving the quality of life for those affected.
DNA Labs UAE offers the PARK7 Parkinson Genetic Test, ensuring high-quality and accurate genetic analysis. The test is priced at 4400 AED, reflecting the sophisticated technology and expertise required to perform the analysis. Conducted in a state-of-the-art facility, the test results are provided with comprehensive explanations, making it easier for individuals and their healthcare providers to understand the implications and consider appropriate steps for management or intervention.
The LRRK2 Gene PARK8 Parkinson Genetic Test is a specialized diagnostic tool designed to identify mutations in the LRRK2 gene, which is known to be a significant genetic factor in the development of Parkinson's disease. This gene, also referred to as PARK8, plays a crucial role in the functioning of neurons in the brain, and mutations within this gene can lead to the onset of Parkinson's disease, characterized by symptoms such as tremors, stiffness, and difficulty with balance and coordination.
Offered at DNA Labs UAE, this test is aimed at individuals who have a family history of Parkinson's disease or are experiencing symptoms associated with the condition, providing them with valuable information regarding their genetic predisposition. The process involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed in the laboratory to detect any alterations in the LRRK2 gene.
The cost of the LRRK2 Gene PARK8 Parkinson Genetic Test at DNA Labs UAE is 4400 AED. This investment can be invaluable for individuals seeking early detection and a deeper understanding of their risk factors for developing Parkinson's disease. Early diagnosis can significantly impact management and treatment options, potentially improving quality of life.
The ATP13A2 gene, also known as PARK9, plays a crucial role in the genetic landscape of Parkinson's disease, a progressive neurological disorder that affects movement. Mutations in the ATP13A2 gene are linked to a rare form of Parkinson's disease, often associated with early onset and additional symptoms beyond the classical movement issues, such as cognitive impairment and psychiatric symptoms.
The ATP13A2 Gene PARK9 Parkinson Genetic Test is a specialized diagnostic tool designed to detect mutations in the ATP13A2 gene. This test is particularly relevant for individuals who have a family history of Parkinson's disease or exhibit symptoms at an unusually young age. Identifying mutations in the ATP13A2 gene can aid in the accurate diagnosis of the condition, influence treatment strategies, and provide valuable information for family planning.
The test is available at DNA Labs UAE, a leading provider of genetic testing services in the United Arab Emirates. DNA Labs UAE employs state-of-the-art technology and adheres to stringent quality control measures to ensure the accuracy and reliability of their test results.
The cost of the ATP13A2 Gene PARK9 Parkinson Genetic Test at DNA Labs UAE is 4400 AED. This price includes the collection of a DNA sample, usually through a blood draw or cheek swab, the genetic analysis, and a comprehensive report detailing the findings. Individuals interested in undergoing this test are advised to consult with a healthcare professional or a genetic counselor to discuss the potential implications of the test results for themselves and their family members.
The "GBA Gene Parkinson Disease Late-Onset Susceptibility to Genetic Test" is a specific diagnostic tool offered by DNA Labs UAE, designed to assess an individual's genetic predisposition to developing late-onset Parkinson's disease. This test focuses on mutations in the GBA gene, which have been linked to an increased risk of Parkinson's disease, a progressive neurological disorder that affects movement. The presence of certain mutations in the GBA gene can significantly elevate an individual's likelihood of developing this condition later in life.
At a cost of 4400 AED, the test provides a valuable insight for those who have a family history of Parkinson's disease or exhibit early symptoms, enabling them to take proactive measures in managing their health. Conducted in the state-of-the-art facilities of DNA Labs UAE, the test involves a simple sample collection process, followed by comprehensive genetic analysis to identify any mutations associated with an increased risk of Parkinson's disease. The results from this test can guide individuals in making informed decisions regarding their health and lifestyle, potentially influencing treatment plans and preventive strategies to mitigate the impact of the disease.
The MT-TT gene, located within the mitochondrial genome, plays a crucial role in the proper functioning of mitochondria, the cell's energy-producing structures. Mutations in the MT-TT gene have been linked to an increased susceptibility to Parkinson's disease, a progressive neurological disorder characterized by motor symptoms such as tremors, stiffness, and bradykinesia, as well as non-motor symptoms. Understanding one's genetic predisposition to Parkinson's disease can be crucial for early detection, management, and potential preventive measures.
DNA Labs UAE offers a specialized genetic test aimed at identifying mutations in the MT-TT gene that may increase an individual's susceptibility to Parkinson's disease. This test is a valuable tool for those with a family history of Parkinson's or individuals who wish to assess their genetic risk for the disease. The test is priced at 4400 AED and involves a simple procedure to collect a DNA sample, typically through a blood draw or cheek swab. The collected sample is then analyzed in the lab to detect any genetic alterations in the MT-TT gene that might indicate a higher risk of developing Parkinson's disease.
Opting for the MT-TT related genetic test at DNA Labs UAE can empower individuals with crucial information about their health, allowing them to make informed decisions regarding their lifestyle, health monitoring, and potential interventions. It's an investment in one's health that could potentially alter the course of their life by providing the opportunity for early intervention and personalized health strategies.
The ATP6AP2 gene has been identified as a critical player in the development of a unique form of Parkinsonism characterized by spasticity, following an X-linked inheritance pattern. This condition, which combines features of Parkinson's disease with muscle stiffness and spasms, has led to the development of specialized genetic testing to diagnose the disorder accurately.
The genetic test for ATP6AP2 gene-related Parkinsonism with spasticity is available at DNA Labs UAE, a leading facility in genetic diagnostics. The test specifically targets mutations within the ATP6AP2 gene to confirm the diagnosis, enabling healthcare professionals to tailor treatment and management plans for affected individuals.
Priced at 4400 AED, the test is a valuable tool for families with a history of X-linked Parkinsonism with spasticity, offering them a clear understanding of their genetic status. This information is crucial for making informed decisions about future healthcare and for understanding the risk to other family members.
The SLC6A3 gene Parkinsonism-Dystonia Infantile genetic test is a specialized diagnostic tool designed to detect mutations in the SLC6A3 gene, which have been associated with the development of Parkinsonism-Dystonia in infancy. This rare genetic disorder is characterized by a combination of Parkinsonian symptoms such as tremors, rigidity, and bradykinesia, alongside dystonia, which involves involuntary muscle contractions leading to abnormal postures or movements. Early detection through genetic testing can be crucial for managing symptoms and improving the quality of life for affected individuals.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test offers a comprehensive analysis of the SLC6A3 gene to identify any mutations that may be present. The process involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed using advanced genetic sequencing technologies.
The cost of the SLC6A3 gene Parkinsonism-Dystonia Infantile genetic test is 4400 AED. While the price may seem significant, the value of early and accurate diagnosis cannot be overstated, as it opens the door to targeted treatments and interventions that can significantly benefit the patient. Individuals with a family history of Parkinsonism-Dystonia or those showing early symptoms of the disorder are encouraged to consider this test. It's also advisable to consult with a healthcare provider or a genetic counselor to understand the implications of the test results fully.
